Capricor Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Duchenne Muscular Dystrophy Therapy
February 05, 2018 11:11 ET
|
Capricor Therapeutics, Inc.
LOS ANGELES, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR) today announced that the U.S. Food and Drug Administration (FDA) has granted CAP-1002, its lead investigational...
Capricor Announces Licensing of Additional Patent Applications from Cedars-Sinai Medical Center for Cellular and Exosome-based Technologies
January 16, 2018 07:00 ET
|
Capricor Therapeutics, Inc.
LOS ANGELES, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR) announced today that it has added seven new patent applications to its existing Exclusive License Agreements with...
Cellular Dynamics and Northwestern University Take First Steps Toward Rebuilding an Organ Using Manufactured Human Cells
November 18, 2014 08:00 ET
|
Cellular Dynamics International, Inc.
MADISON, Wis., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced the publication1 of a study in the American Journal of Transplantation describing a...
Scott Carmer Named as CEO of Orgenesis North America
August 04, 2014 09:00 ET
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Aug 4, 2014) - Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, today announced the appointment of...